aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in

Humans Male Molecular Imaging Positron Emission Tomography Computed Tomography / methods Prostate-Specific Antigen Prostatic Neoplasms / diagnostic imaging Retrospective Studies Tumor Burden Veterans
18F-DCFPyL PSMA aPROMISE quantification segmentation standardization

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2022
Historique:
received: 23 12 2020
revised: 23 04 2021
pubmed: 30 5 2021
medline: 30 4 2022
entrez: 29 5 2021
Statut: ppublish

Résumé

Standardized staging and quantitative reporting are necessary to demonstrate the association of

Identifiants

DOI: 10.2967/jnumed.120.261863 PMID: 34049980
pubmed: 34049980
pii: jnumed.120.261863
doi: 10.2967/jnumed.120.261863
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-239

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Nicholas Nickols (N)

Radiation Oncology Service, VA Greater Los Angeles Healthcare System, Los Angeles, California.
Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California.
Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, California.
Institute of Urologic Oncology, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California.

Aseem Anand (A)

Department of Translational Medicine, Division of Urological Cancer, Lund University, Malmö, Sweden.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Data Science and Machine Learning, EXINI Diagnostic AB, Lund, Sweden.

Kerstin Johnsson (K)

Department of Data Science and Machine Learning, EXINI Diagnostic AB, Lund, Sweden.

Johan Brynolfsson (J)

Department of Data Science and Machine Learning, EXINI Diagnostic AB, Lund, Sweden.

Pablo Borreli (P)

Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Neil Parikh (N)

Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California.

Jesus Juarez (J)

Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California.

Lida Jafari (L)

Imaging Service, VA Greater Los Angeles Healthcare System, Los Angeles, California.

Mattias Eiber (M)

Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; and.

Matthew Rettig (M)

Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California; mrettig@mednet.ucla.edu.
Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, California.
Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Techniques d'investigation › Techniques de sonde moléculaire › Imagerie moléculaire › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigène spécifique de la prostate › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Techniques d'investigation › Charge tumorale › aPROMISE: A Novel Automated PROMISE Platform...
questionsmedicales.fr › Personnes › Anciens combattants › aPROMISE: A Novel Automated PROMISE Platform...